Thursday, 30 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Market pressure seen as fueling too much weight loss in new obesity drugs
Health and Wellness

Market pressure seen as fueling too much weight loss in new obesity drugs

Last updated: February 23, 2025 12:51 am
Share
Market pressure seen as fueling too much weight loss in new obesity drugs
SHARE

Eli Lilly’s next-generation obesity drug, known as retatrutide, is causing unexpected outcomes in ongoing trials. Instead of struggling to lose weight, several participants are actually facing the opposite problem – they are losing too much weight.

One participant experienced a staggering 22% weight loss in just nine months, a rate much faster than what is typically seen with approved GLP-1 drugs like Wegovy or Zepbound. Her weight loss was so significant that researchers had to decrease her dosage of retatrutide. Despite this adjustment, she continued to feel nauseous and eventually started skipping doses on her own.

Another participant, who lost 30% of his weight in eight months, developed a kidney stone. While it is unclear if this was directly related to the weight loss, a recent observational study linked GLP-1 drugs to an increased risk of kidney stones.

A third patient saw a 31% decrease in weight over a similar timeframe and has resorted to consuming calorie-dense foods like peanut butter to prevent further weight loss. He expressed his disbelief at the irony of being in an obesity trial and actively trying to avoid losing more weight.

While these participants, all in their 40s and 50s, have found the drug to be life-changing in terms of weight loss and improved health conditions like knee pain, high cholesterol, and fatty liver disease, they are also grappling with the extreme weight loss effects of the medication.

Despite the challenges they are facing, the participants are grateful for the positive impact the drug has had on their lives. They have not been informed whether they are receiving the actual treatment or a placebo, but based on their significant weight loss, they believe they are part of the treatment group.

See also  Is the GLP-1 party running down for Hims, and a study for the weekend

The unexpected issue of excessive weight loss in these trial participants sheds light on the potential power of Eli Lilly’s next-generation obesity drug. As further research and trials continue, it will be crucial to monitor and address any unexpected side effects or outcomes that may arise.

TAGGED:DrugsFuelingLossmarketObesitypressureWeight
Share This Article
Twitter Email Copy Link Print
Previous Article Musk orders US federal workers to report on work by Monday or resign Musk orders US federal workers to report on work by Monday or resign
Next Article Oversight Democrats Demand That Trump Abandon Illegal Plan To Dismantle USPS Oversight Democrats Demand That Trump Abandon Illegal Plan To Dismantle USPS
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Jennifer Lopez’s New Romance ‘Doomed’

Jennifer Lopez's New Romance: A Welcome Distraction? After the collapse of her high-profile marriage and…

June 4, 2025

Scientists Have Pinpointed The Best Diets to Boost Healthy Aging : ScienceAlert

How Your Diet Can Influence Healthy Aging As we all age, some of us may…

April 11, 2025

A Working Man Review: So Bad I Cried Laughing

From the very first scene of "A Working Man," it is clear that this action…

March 28, 2025

‘Habitual juvenile offender’ on ankle monitor carjacked disabled woman at gunpoint, officials say

Kennedy Leach, an 18-year-old labeled as a “habitual juvenile offender” by officials, has been charged…

July 19, 2025

Constellation Brands, Inc. (STZ): A Bull Case Theory

Recently, we discovered an insightful bullish thesis on Constellation Brands, Inc. by Justin on Slo…

September 30, 2025

You Might Also Like

Blue Cross’ new algorithm for health care costs infuriates doctors
Health and Wellness

Blue Cross’ new algorithm for health care costs infuriates doctors

October 30, 2025
Eating patterns may be more closely tied to seasonal rhythms than previously thought
Health and Wellness

Eating patterns may be more closely tied to seasonal rhythms than previously thought

October 30, 2025
Trump turns up the pressure on Indiana Republicans to redistrict
Politics

Trump turns up the pressure on Indiana Republicans to redistrict

October 30, 2025
With A Doctor Shortage; Is Concierge Medicine Morally Acceptable?
Health and Wellness

With A Doctor Shortage; Is Concierge Medicine Morally Acceptable?

October 30, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?